Global Degenerative Disc Disease Treatment Market Revenue and Share Analysis Through 2029
Uncover key drivers, emerging technologies, and competitive movements shaping the degenerative disc disease treatment market from 2025–2034 with trusted insights from The Business Research Company
What Is The Projected Valuation Of The Degenerative Disc Disease Treatment Market In The Period 2029-2034?
The market for degenerative disc disease treatments has experienced robust growth recently. Projections indicate it will expand from $27.07 billion in 2024 to $28.79 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 6.3%. This historical expansion can be linked to factors such as an aging demographic, prevalent sedentary lifestyles, advancements in medical technology, heightened awareness, increasing rates of obesity, a rise in sports-related injuries, and the broadening of healthcare access.
The degenerative disc disease treatment market is projected to experience substantial expansion over the coming years. This market is anticipated to reach a valuation of $37.41 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this growth during the forecast period include an increase in healthcare spending, an increasing preference for minimally invasive procedures, improved patient understanding, a rise in clinical research activities, and the growing worldwide occurrence of spine disorders. Key trends expected within this period encompass the incorporation of AI and machine learning, the progression of regenerative medicine, innovations in minimally invasive surgical techniques, the adoption of wearable technology, the use of 3D printing for customized implants, the rise of telemedicine and remote consultations, and an emphasis on individualized medical care.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18784&type=smp
What Strategic Drivers Are Accelerating The Degenerative Disc Disease Treatment Market Expansion?
The degenerative disc disease treatment market is anticipated to expand going forward due to an increase in sports injuries. Sports injuries are defined as physical damage or trauma sustained by athletes or individuals engaged in physical activities, often resulting from sudden impacts, overuse, or improper techniques. The surge in sports injuries is commonly linked to factors such as higher participation rates, more intense training regimens, and a greater emphasis on competitive performance. Degenerative disc disease treatment is applied in the context of sports injuries to manage chronic spinal pain and restore function when disc degeneration impacts athletes’ performance and mobility. For instance, in November 2023, Howden Group Holdings Ltd, a UK-based insurance intermediary company, reported that injuries recorded in October 2022 led to players being sidelined for an average of 11.35 days before tournaments, rising to 19.41 days by January 2023. Consequently, the increasing incidence of sports injuries is driving the growth of the degenerative disc disease treatment market.
What Is The Detailed Segment Distribution Of The Degenerative Disc Disease Treatment Market?
The degenerative disc disease treatmentmarket covered in this report is segmented –
1) By Type: Conventional Drugs, Novel Therapies
2) By Route Of Administration: Oral, Injectable
3) By End User: Hospitals, Ambulatory Surgical Centers, Orthopedic Center
Subsegments:
1) By Conventional Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Muscle Relaxants, Corticosteroids, Antidepressants
2) By Novel Therapies: Gene Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Biologic Agents, Regenerative Medicine, Cell-Based Therapies, Growth Factor Therapies
How Are Global Trends Impacting The Development Of The Degenerative Disc Disease Treatment Market?
Key players in the degenerative disc disease treatment market are concentrating on creating innovative therapies, such as injectable disc cell therapy (IDCT), to enhance patient results by boosting disc volume, relieving low back pain, and decreasing reliance on pain medications. This regenerative treatment, IDCT, specifically targets symptomatic lumbar degenerative disc disease. For example, in February 2023, DiscGenics Inc., a US-based biopharmaceutical company, was granted FDA regenerative medicine advanced therapy designation for its injectable disc cell therapy (IDCT), which aims to treat symptomatic lumbar degenerative disc disease. This innovative therapy employs a live progenitor cell population derived from donated adult human intervertebral disc tissue. IDCT holds the potential to increase disc volume, mitigate low back pain, and reduce the need for pain medication in patients affected by the condition.
Who Are The Major Stakeholders Operating In The Degenerative Disc Disease Treatment Market?
Major companies operating in the degenerative disc disease treatment market are Pfizer Inc., Johnson And Johnson, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline PLC, Medtronic plc, Amgen Inc., Baxter International Inc., B. Braun SE, Zimmer Biomet Holdings Inc., Arthrex Inc., Ferring B.V., Biocon Limited, Integra LifeSciences Holdings Corporation, NuVasive Inc., Globus Medical Inc., Orthofix Medical Inc., RTI Surgical Holdings Inc., LifeNet Health
Download The Full Report Here:
Which Region Is Projected To Achieve The Fastest Growth In The Degenerative Disc Disease Treatment Market?
North America was the largest region in the degenerative disc disease treatment market in 2024. The regions covered in the degenerative disc disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=18784&type=smp
Browse Through More Reports Similar to the Global Degenerative Disc Disease Treatment Market 2025, By The Business Research Company
Neurodegenerative Disorder Therapeutic Global Market Report 2025
Inflammatory Bowel Disease Treatment Global Market Report 2025
Chronic Disease Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/chronic-disease-management-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
